Improvement of cognitive impairment in female type 2 diabetes mellitus mice by spironolactone

GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone

(2011) Robert Gros et al.   HYPERTENSION

GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance

(2010) R. Hammond et al.   BRAIN RESEARCH

High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension

(2010) Shusuke Yagi et al.   HYPERTENSION RESEARCH

Female exhibited severe cognitive impairment in type 2 diabetes mellitus mice

(2010) Akiko Sakata et al.   LIFE SCIENCES

Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines

(2008) Christine Guo et al.   CIRCULATION

Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles

(2008) K. Swaminathan et al.   DIABETOLOGIA

The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia

(2008) Naofumi Oyamada et al.   ENDOCRINOLOGY

Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons

(2008) Alexis M Stranahan et al.   NATURE NEUROSCIENCE